TWI256304B - Pharmaceutical compositions based on azetidine derivatives - Google Patents

Pharmaceutical compositions based on azetidine derivatives

Info

Publication number: TWI256304B
Authority: TW; Taiwan
Prior art keywords: pharmaceutical compositions; compositions based; azetidine derivatives; derivatives; azetidine
Prior art date: 2001-12-21

Application number

TW091135077A

Other languages

English (en)

Other versions

TW200301108A (en

Inventor

Sophie Cote

Valerie Bobineau

Maria-Teresa Peracchia

Original Assignee

Aventis Pharma Sa

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2001-12-21

Filing date

2002-12-03

Publication date

2006-06-11

2002-12-03 Application filed by Aventis Pharma Sa filed Critical Aventis Pharma Sa

2003-07-01 Publication of TW200301108A publication Critical patent/TW200301108A/zh

2006-06-11 Application granted granted Critical

2006-06-11 Publication of TWI256304B publication Critical patent/TWI256304B/zh

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/397—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having four-membered rings, e.g. azetidine
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4841—Filling excipients; Inactive ingredients
- A61K9/4858—Organic compounds
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Veterinary Medicine (AREA)
Pharmacology & Pharmacy (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Epidemiology (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Organic Chemistry (AREA)
Neurosurgery (AREA)
Neurology (AREA)
Biomedical Technology (AREA)
Oil, Petroleum & Natural Gas (AREA)
Psychiatry (AREA)
Obesity (AREA)
Hematology (AREA)
Diabetes (AREA)
Psychology (AREA)
Child & Adolescent Psychology (AREA)
Hospice & Palliative Care (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicinal Preparation (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Plural Heterocyclic Compounds (AREA)

TW091135077A 2001-12-21 2002-12-03 Pharmaceutical compositions based on azetidine derivatives TWI256304B (en)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
FR0116638A FR2833842B1 (fr)	2001-12-21	2001-12-21	Compositions pharmaceutiques a base de derives d'azetidine

Publications (2)

Publication Number	Publication Date
TW200301108A TW200301108A (en)	2003-07-01
TWI256304B true TWI256304B (en)	2006-06-11

Family

ID=8870824

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
TW091135077A TWI256304B (en)	2001-12-21	2002-12-03	Pharmaceutical compositions based on azetidine derivatives

Country Status (32)

Country	Link
EP (1)	EP1458413B1 (zh)
JP (1)	JP5021887B2 (zh)
KR (1)	KR20040068308A (zh)
CN (1)	CN100388918C (zh)
AP (1)	AP1754A (zh)
AR (1)	AR037687A1 (zh)
AU (1)	AU2002364866B2 (zh)
BR (1)	BR0215048A (zh)
CA (1)	CA2470443A1 (zh)
CO (1)	CO5590911A2 (zh)
DE (1)	DE60233071D1 (zh)
DK (1)	DK1458413T3 (zh)
EA (1)	EA006510B1 (zh)
EC (1)	ECSP045162A (zh)
FR (1)	FR2833842B1 (zh)
HK (1)	HK1070840A1 (zh)
HR (1)	HRP20040575A2 (zh)
HU (1)	HUP0402586A3 (zh)
IL (1)	IL162563A0 (zh)
MA (1)	MA27086A1 (zh)
ME (1)	MEP16608A (zh)
MX (1)	MXPA04005558A (zh)
MY (1)	MY138172A (zh)
NO (1)	NO20042781L (zh)
NZ (1)	NZ533225A (zh)
OA (1)	OA12750A (zh)
PL (1)	PL203248B1 (zh)
RS (1)	RS55504A (zh)
TW (1)	TWI256304B (zh)
UA (1)	UA77736C2 (zh)
WO (1)	WO2003053431A2 (zh)
ZA (1)	ZA200404338B (zh)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
EP1498123A1 (en) *	2003-07-18	2005-01-19	Aventis Pharma S.A.	Emulsifying systems containing azetidine derivatives
EP1498122A1 (en) *	2003-07-18	2005-01-19	Aventis Pharma S.A.	Semi-solid systems containing azetidine derivatives
KR20060124756A (ko)	2004-02-17	2006-12-05	라보라토리오스 델 드라. 에스테브.에스.에이.	치환된 아제티딘 화합물, 그 제조 및 약제로써의 용도
FR2879932B1 (fr) *	2004-12-27	2007-03-23	Aventis Pharma Sa	Formulations injectable ou administrable par voie orale de derives d'azetidine
KR20080027908A (ko)	2005-06-30	2008-03-28	프로시디온 리미티드	Ｇｐｃｒ 효능제
EA016507B1 (ru)	2007-01-04	2012-05-30	Прозидион Лимитед	Пиперидиновые агонисты gpcr
PE20081849A1 (es)	2007-01-04	2009-01-26	Prosidion Ltd	Derivados de piperidin-4-il-propoxi-benzamida como agonistas de gpcr
US20100048632A1 (en)	2007-01-04	2010-02-25	Matthew Colin Thor Fyfe	Piperidine GPCR Agonists
GB0700122D0 (en)	2007-01-04	2007-02-14	Prosidion Ltd	GPCR agonists
PE20081659A1 (es)	2007-01-04	2008-10-24	Prosidion Ltd	Agonistas de gpcr
GB0720389D0 (en)	2007-10-18	2008-11-12	Prosidion Ltd	G-Protein Coupled Receptor Agonists
GB0720390D0 (en)	2007-10-18	2007-11-28	Prosidion Ltd	G-Protein coupled receptor agonists
FR2923719B1 (fr) *	2007-11-15	2009-11-20	Sanofi Aventis	Compositions pharmaceutiques a base de derives d'azetidine
FR2928149B1 (fr)	2008-02-29	2011-01-14	Sanofi Aventis	Composes derives d'azetidines, leur preparation et leur application en therapeutique
FR2946650B1 (fr) *	2009-06-16	2011-08-19	Sanofi Aventis	Esters derives d'azetidines, leur preparation et leur application en therapeutique.
UA153183U (uk)	2022-10-27	2023-05-31	Андрій Валерійович Максимов	Стаканчик для приготування напою

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
GR73668B (zh) *	1978-11-21	1984-03-28	Hoffmann La Roche
US5631365A (en) *	1993-09-21	1997-05-20	Schering Corporation	Hydroxy-substituted azetidinone compounds useful as hypocholesterolemic agents
HRP980026A2 (en) *	1998-01-20	1999-10-31	Pliva Pharm & Chem Works	1-izothiazolydinone derivatives of azetidine-2-ones, processes for the preparation and use thereof
CA2302735A1 (en) *	1998-07-14	2000-01-27	Em Industries, Inc.	Microdisperse drug delivery systems
FR2783246B1 (fr) *	1998-09-11	2000-11-17	Aventis Pharma Sa	Derives d'azetidine, leur preparation et les medicaments les contenant
FR2805818B1 (fr) *	2000-03-03	2002-04-26	Aventis Pharma Sa	Derives d'azetidine, leur preparation et les compositions pharmaceutiques les contenant
FR2805810B1 (fr) *	2000-03-03	2002-04-26	Aventis Pharma Sa	Compositions pharmaceutiques contenant des derives de 3- amino-azetidine, les nouveaux derives et leur preparation
FR2805817B1 (fr) *	2000-03-03	2002-04-26	Aventis Pharma Sa	Compositions pharmaceutiques contenant des derives d'azetidine, les nouveaux derives d'azetidine et leur preparation
FR2814678B1 (fr) *	2000-10-04	2002-12-20	Aventis Pharma Sa	Association d'un antagoniste du recepteur cb1 et de sibutramine, les compositions pharmaceutiques les contenant et leur utilisation pour la traitement de l'obesite

2001
- 2001-12-21 FR FR0116638A patent/FR2833842B1/fr not_active Expired - Fee Related
2002
- 2002-12-02 AR ARP020104646A patent/AR037687A1/es unknown
- 2002-12-03 TW TW091135077A patent/TWI256304B/zh active
- 2002-12-20 MX MXPA04005558A patent/MXPA04005558A/es active IP Right Grant
- 2002-12-20 NZ NZ533225A patent/NZ533225A/en not_active IP Right Cessation
- 2002-12-20 AP APAP/P/2004/003066A patent/AP1754A/en active
- 2002-12-20 DK DK02801165T patent/DK1458413T3/da active
- 2002-12-20 WO PCT/FR2002/004514 patent/WO2003053431A2/fr active IP Right Grant
- 2002-12-20 OA OA1200400178A patent/OA12750A/fr unknown
- 2002-12-20 HU HU0402586A patent/HUP0402586A3/hu unknown
- 2002-12-20 MY MYPI20024828A patent/MY138172A/en unknown
- 2002-12-20 EA EA200400843A patent/EA006510B1/ru not_active IP Right Cessation
- 2002-12-20 RS YUP-555/04A patent/RS55504A/sr unknown
- 2002-12-20 AU AU2002364866A patent/AU2002364866B2/en not_active Ceased
- 2002-12-20 DE DE60233071T patent/DE60233071D1/de not_active Expired - Lifetime
- 2002-12-20 CA CA002470443A patent/CA2470443A1/fr not_active Abandoned
- 2002-12-20 IL IL16256302A patent/IL162563A0/xx unknown
- 2002-12-20 PL PL372708A patent/PL203248B1/pl not_active IP Right Cessation
- 2002-12-20 KR KR10-2004-7009708A patent/KR20040068308A/ko not_active Application Discontinuation
- 2002-12-20 UA UA20040706001A patent/UA77736C2/uk unknown
- 2002-12-20 EP EP02801165A patent/EP1458413B1/fr not_active Expired - Lifetime
- 2002-12-20 CN CNB028248406A patent/CN100388918C/zh not_active Expired - Fee Related
- 2002-12-20 JP JP2003554188A patent/JP5021887B2/ja not_active Expired - Fee Related
- 2002-12-20 ME MEP-166/08A patent/MEP16608A/xx unknown
- 2002-12-20 BR BR0215048-4A patent/BR0215048A/pt not_active IP Right Cessation
2004
- 2004-05-21 MA MA27694A patent/MA27086A1/fr unknown
- 2004-06-02 ZA ZA200404338A patent/ZA200404338B/en unknown
- 2004-06-17 CO CO04056913A patent/CO5590911A2/es not_active Application Discontinuation
- 2004-06-18 EC EC2004005162A patent/ECSP045162A/es unknown
- 2004-06-18 HR HR20040575A patent/HRP20040575A2/hr not_active Application Discontinuation
- 2004-07-01 NO NO20042781A patent/NO20042781L/no not_active Application Discontinuation
2005
- 2005-05-04 HK HK05103765A patent/HK1070840A1/xx not_active IP Right Cessation

Also Published As

Publication number	Publication date
JP5021887B2 (ja)	2012-09-12
FR2833842B1 (fr)	2004-02-13
RS55504A (en)	2007-06-04
MXPA04005558A (es)	2004-12-06
NO20042781L (no)	2004-09-20
MA27086A1 (fr)	2004-12-20
PL372708A1 (en)	2005-07-25
CA2470443A1 (fr)	2003-07-03
HUP0402586A2 (hu)	2005-03-29
OA12750A (fr)	2006-07-03
EA200400843A1 (ru)	2004-12-30
AR037687A1 (es)	2004-12-01
UA77736C2 (en)	2007-01-15
ECSP045162A (es)	2004-08-27
KR20040068308A (ko)	2004-07-30
AP1754A (en)	2007-07-18
HUP0402586A3 (en)	2011-05-30
AU2002364866B2 (en)	2006-11-30
ZA200404338B (en)	2005-06-02
EA006510B1 (ru)	2005-12-29
WO2003053431A2 (fr)	2003-07-03
EP1458413B1 (fr)	2009-07-22
BR0215048A (pt)	2004-11-03
IL162563A0 (en)	2005-11-20
CN100388918C (zh)	2008-05-21
JP2005516945A (ja)	2005-06-09
NZ533225A (en)	2007-02-23
CN1602206A (zh)	2005-03-30
MEP16608A (en)	2010-06-10
DK1458413T3 (da)	2009-11-23
TW200301108A (en)	2003-07-01
MY138172A (en)	2009-04-30
EP1458413A2 (fr)	2004-09-22
HK1070840A1 (en)	2005-06-30
PL203248B1 (pl)	2009-09-30
AU2002364866A1 (en)	2003-07-09
CO5590911A2 (es)	2005-12-30
FR2833842A1 (fr)	2003-06-27
DE60233071D1 (de)	2009-09-03
AP2004003066A0 (en)	2004-06-30
WO2003053431A3 (fr)	2003-12-18
HRP20040575A2 (en)	2004-10-31

Publication	Publication Date	Title
MXPA03004549A (es)	2004-03-26	Derivados de 3-arilindola y su uso como agonistas del receptor cb2.
TWI256304B (en)	2006-06-11	Pharmaceutical compositions based on azetidine derivatives
YU80902A (sh)	2005-11-28	Novi indolin-2-on derivati, njihovo dobijanje i farmaceuski oblici koji ih sadrže
AP1718A (en)	2007-01-30	3-(4-amidopyrrol-2-ylmethlidene)-2-indolinone derivatives as protein kinase inhibitors
MXPA03011197A (es)	2004-02-26	Benzoilsufonamidas y sulfonilbenzamidinas que se usan como agentes antitumorales.
AU2002350961A1 (en)	2003-06-30	Ethylene diamine derivatives and their use as orexin-receptor antagonists
NO20043022L (no)	2004-07-15	5,6-diaryl-pyrazin-2-amid-derivater som CB1-antagonister
MY136969A (en)	2008-12-31	Mpeg table structure
IL161857A0 (en)	2005-11-20	Pharmaceutical compositions of 5,7,14-triazatetracycloÄ10.3.1.0(2,11).0(4,9)Ü-hexadeca-2(11)3,5,7,9-pentaene
AU6468001A (en)	2001-11-26	Cannabinoid drugs
MXPA04003886A (es)	2004-07-08	Tiofen- y tiazolsulfonamidas como agentes antineoplasticos.
EP1420787B8 (en)	2010-09-01	Ophthalmic composition comprising an ascomycin
IL162451A0 (en)	2005-11-20	5Ht4 partial agonist pharmaceutical compositions
IL161582A0 (en)	2004-09-27	Use of oxindole hydrazide derivatives for the preparation of pharmaceutical compositions, certain such new derivatives and their preparation
DK1097173T3 (da)	2008-09-01	Anvendelse af peptider af IL-2 og derivater deraf som terapeutiske midler
EP1426370A4 (en)	2009-12-23	PROPANOLAMINE DERIVATIVE WITH 1,4-BENZODIOXANE CORE
AU2003290592A1 (en)	2004-06-18	Antitumor benzoylsulfonamides
MXPA03009383A (es)	2004-01-29	DERIVADOS DE HETEROCICLIL ETER DE FENILO COMO INHIBIDORES DE LA REABSORCIoN DE SEROTONINA.
WO2003097597A3 (fr)	2004-04-01	Derives d'indole et leur utilisation en tant que ligands des recepteurs cb2
EG23207A (en)	2004-07-31	Novel fungicidal compositions based on propamocarsand pyridylmethylbenzamide derivatives.
AU2002248531A1 (en)	2002-09-24	Pyrazolopyriadine derivatives
AU2002331595A1 (en)	2003-03-03	Novel vasoconstrictor cannabinoid analogs
PL380665A1 (pl)	2007-03-05	Farmaceutyczne kompozycje
AU2002357740A1 (en)	2003-06-23	Pyrazolo-pyridine derivatives as antiherpes agents
YU83903A (sh)	2006-08-17	Farmaceutske kombinacije zasnovane na derivatima piridoindolona